ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,310Medicare Part D Prescriptions Filled, Including Refills

Rank: 100 out of 2094

$628K Total Retail Price of All Prescriptions

Rank: 321 out of 2094

475 Patients Receiving at Least One Drug in Part D
56%Patients 65 Years and Older
90% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

17% of this provider’s 475 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

12% of this provider’s 475 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

1% of this provider’s 7,745 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 32%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
LISINOPRIL 738 500 1 7
SIMVASTATIN 643 471 2 1
OMEPRAZOLE 576 325 3 4
METFORMIN HCL 549 381 4 8
METOPROLOL TARTRATE 349 255 5 10
AMLODIPINE BESYLATE 329 251 6 2
HYDROCHLOROTHIAZIDE 316 197 7 12
LEVOTHYROXINE SODIUM 309 162 8 3
ZOLPIDEM TARTRATE 300 160 9 14
FUROSEMIDE 275 185 10 6
HYDROCODONE-ACETAMINOPHEN 225 167 S3 11 42
ATORVASTATIN CALCIUM 218 165 12 5
CARVEDILOL 187 148 13 19
PROAIR HFA 164 110 14 45
ALLOPURINOL 162 111 15 50
TRAMADOL HCL 157 52 16 33
ALENDRONATE SODIUM 151 108 17 30
PRAVASTATIN SODIUM 149 83 18 18
CHLORTHALIDONE 148 120 19 200
INSULIN SYRINGE 142 106 20 143
LANTUS 137 120 21 66
METOPROLOL SUCCINATE 134 59 22 9
ADVAIR DISKUS 132 79 23 36
LANTUS SOLOSTAR 123 56 24 76
WARFARIN SODIUM 119 58 25 11
IBUPROFEN 115 27 26 73
TAMSULOSIN HCL 110 85 27 29
OXYCODONE-ACETAMINOPHEN 106 47 S2 28 40
CLOPIDOGREL 105 70 29 22
FLUTICASONE PROPIONATE 102 52 30 41
GLIPIZIDE 100 59 31 82
GABAPENTIN 99 41 32 23
ENDOCET 97 56 S2 33 88
VENTOLIN HFA 96 44 34 132
MIRTAZAPINE 94 80 35 43
DIOVAN 94 65 35 13
HYDROXYZINE PAMOATE 87 51 R 37 437
HYDROCORTISONE 79 49 38 268
CYCLOBENZAPRINE HCL 79 13 R 38 115
SINGULAIR 78 33 40 64
SERTRALINE HCL 73 35 41 26
GLIMEPIRIDE 71 48 42 31
ENALAPRIL MALEATE 70 52 43 25
NEXIUM 70 28 43 16
OXYCONTIN 66 0 S2 45 98
FAMOTIDINE 66 51 45 34
COLCRYS 65 33 47 230
ISOSORBIDE MONONITRATE ER 64 58 48 57
PLAVIX 62 40 49 38
PANTOPRAZOLE SODIUM 61 39 50 37
LYRICA 60 28 51 85
MONTELUKAST SODIUM 59 27 52 128
OXYBUTYNIN CHLORIDE 57 46 53 224
GLIPIZIDE XL 56 30 54 122
HUMALOG MIX 75-25 56 55 54 273
LISINOPRIL-HYDROCHLOROTHIAZIDE 56 42 54 55
ACETAMINOPHEN-CODEINE 55 37 S3 57 129
FENTANYL 53 11 S2 58 68
CLOTRIMAZOLE-BETAMETHASONE 51 43 59 91
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 30, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.